The World’s leading clinical trials event returns to Latin America for the third time, bringing more global leaders to share perspectives on the latest global trends and clinical outsourcing and development strategies.
More than 400 clinical executives have participated in this event since it launched in Argentina in 2010. Each year, the event attendance has doubled attracting more new companies and clinical leaders to accelerate innovation, increase efficiency, and improve quality of clinical research and operations in Latin America. See who has benefited from attending…
Perspectives on Global Sourcing and Spending of Clinical Trial Investments Around the World - a comprehensive overview of the evolving clinical trial outsourcing landscape with an eye toward financial considerations, including the impact of M&A on clinical trials in LATAM, Wall Street's Perspective, and case studies to help guide your strategic decision making.
John Kregar, Principal, Healthcare Equity Research Analyst, William Blair & Company
Creating Transformational Change: How to Retool R&D to Produce More, Better, and Affordable Innovation - a close look at how R&D models are changing and how the industry could translate innovation research into better business models through strategic partnerships and collaborative initiatives that will result in increased output of new medicines.
Bernard Munos, Chief Apostle, Breakthrough Innovation, Innothink Center for Research in Biomedical Innovation
Tapping into the Promise of Regenerative Medicine in Latin America - a comprehensive look at the current happenings in the field of regenerative medicine especially in the areas of cell therapies and tissue engineering with a focus on future opportunities for the Latin America region.
Abner Mhashilkar, PhD, Medical Translation Officer, WFIRM, Wake Forest School of Medicine
Keynote: Avoid Unwanted Surprises in Outsourcing: Lessons Learned on How to Build Effective Partnerships with CROs in Latin America Jeffrey S. Kasher, PhD, Vice President and Chief Operating Officer, Global Clinical Development, Eli Lilly
Best Practices for Proactive Quality Management Patricia Leucthen, CEO, The Avoca Group
Monitoring for Quality: Implement Risk-Based Clinical Monitoring in Latin America Jon Lee, Vice President, Development Operations, Cerexa
Latin America R&D Innovation Consortium – An interactive forum focused on bringing together regional R&D leadership to create solutions to shared challenges. This moderated discussion will enable you to:
✔ Learn how to accelerate innovation and pipeline development
✔ Leverage strategic partnering to drive innovation
✔ Improve Latin America's competitive position in the global marketplace